These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 26270676)

  • 21. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem cells: progress and challenges in lung cancer.
    Templeton AK; Miyamoto S; Babu A; Munshi A; Ramesh R
    Stem Cell Investig; 2014; 1():9. PubMed ID: 27358855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting crosstalk of signaling pathways in cancer stem cells: a promising approach for development of novel anti-cancer therapeutics.
    Bhal S; Kundu CN
    Med Oncol; 2023 Jan; 40(2):82. PubMed ID: 36662310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenic trioxide inhibits the growth of cancer stem cells derived from small cell lung cancer by downregulating stem cell-maintenance factors and inducing apoptosis via the Hedgehog signaling blockade.
    Chang KJ; Yin JZ; Huang H; Li B; Yang MH
    Transl Lung Cancer Res; 2020 Aug; 9(4):1379-1396. PubMed ID: 32953511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on immune-based therapy strategies targeting cancer stem cells.
    Izadpanah A; Mohammadkhani N; Masoudnia M; Ghasemzad M; Saeedian A; Mehdizadeh H; Poorebrahim M; Ebrahimi M
    Cancer Med; 2023 Sep; 12(18):18960-18980. PubMed ID: 37698048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
    Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
    Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
    Wang R; Wei J; Zhang S; Wu X; Guo J; Liu M; Du K; Xu J; Peng L; Lv Z; You W; Xiong Y; Fu Z
    Oncotarget; 2016 Dec; 7(52):86816-86828. PubMed ID: 27894099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
    Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
    Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of breast cancer stem cell features.
    Czerwinska P; Kaminska B
    Contemp Oncol (Pozn); 2015; 19(1A):A7-A15. PubMed ID: 25691826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lung cancer stem cells-origin, characteristics and therapy.
    Prabavathy D; Swarnalatha Y; Ramadoss N
    Stem Cell Investig; 2018; 5():6. PubMed ID: 29682513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotargeting of Cancer Stem Cells.
    Köseer AS; Di Gaetano S; Arndt C; Bachmann M; Dubrovska A
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A concise review on the current understanding of pancreatic cancer stem cells.
    Vaz AP; Ponnusamy MP; Seshacharyulu P; Batra SK
    J Cancer Stem Cell Res; 2014; 2():. PubMed ID: 26451384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insight into hedgehog signaling in hematological malignancies.
    Geng L; Wang X
    Leuk Lymphoma; 2015 Apr; 56(4):858-65. PubMed ID: 24991722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia.
    Wu A; Turner KA; Woolfson A; Jiang X
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence.
    Aramini B; Masciale V; Grisendi G; Bertolini F; Maur M; Guaitoli G; Chrystel I; Morandi U; Stella F; Dominici M; Haider KH
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA-cCSC1 modulates cancer stem cell properties in colorectal cancer via activation of the Hedgehog signaling pathway.
    Zhou H; Xiong Y; Peng L; Wang R; Zhang H; Fu Z
    J Cell Biochem; 2020 Mar; 121(3):2510-2524. PubMed ID: 31680315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting cancer stem cells in drug discovery: Current state and future perspectives.
    Du FY; Zhou QF; Sun WJ; Chen GL
    World J Stem Cells; 2019 Jul; 11(7):398-420. PubMed ID: 31396368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.